...
机译:肿瘤化疗栓塞期间的骨骼肌体积损失预测肝细胞癌患者的预后差
Department of GastroenterologyFukushima Medical University School of MedicineFukushima Japan;
Department of GastroenterologyFukushima Medical University School of MedicineFukushima Japan;
Department of GastroenterologyFukushima Medical University School of MedicineFukushima Japan;
Department of GastroenterologyFukushima Medical University School of MedicineFukushima Japan;
Department of GastroenterologyFukushima Medical University School of MedicineFukushima Japan;
Department of GastroenterologyFukushima Medical University School of MedicineFukushima Japan;
hepatocellular carcinoma; sarcopenia; skeletal muscle volume loss; transarterial chemoembolization;
机译:肿瘤化疗栓塞期间的骨骼肌体积损失预测肝细胞癌患者的预后差
机译:肝细胞癌的结节数目而非大小可预测难治性经动脉化疗栓塞和不良预后
机译:FDG PET / CT代谢肿瘤体积对无肝外转移的肝细胞癌患者经动脉化学栓塞和经动脉化疗输注的预测价值
机译:改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:肝细胞癌的结节数目而不是大小可以预测难治性经动脉化疗栓塞和不良预后
机译:结节数但不肝细胞癌的大小可以预测易转化的肿瘤栓塞和预后差的耐火性